摘要
通过对1例英夫利昔单抗治疗炎症性肠病引起血清病样反应的病例分析,结合中国知网、万方数据库、维普数据库及PubMed等数据库文献复习,探讨该不良反应的发生机制及防治措施,以加强对英夫利昔单抗引起的少见血清病样不良反应的认识,提醒临床医师应对此不良反应予以重视,提高药物治疗的安全性和有效性。
By analyzing a case of serum sickness-like adverse reactions caused by infliximab for inflammatory bowel disease and performing a literature review,the mechanism and prevention measures of the adverse reactions caused by infliximab were discussed,and the recognition of rare serological sick-like adverse reactions caused by Infliximab was enhanced.Clinicians should pay attention to this adverse reaction and improve the safety and effectiveness of drug therapy.
作者
王雪芹
李冬艳
吴菲
WANG Xueqin;LI Dongyan;WU Fei(Department of Pharmacy,Taihe Hospital Affiliated with Hubei University of Medicine,Hubei Shiyan 442000,China;Department of Pharmacy,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Faculty of Internal Medicine,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China)
出处
《医药导报》
CAS
北大核心
2023年第4期597-600,共4页
Herald of Medicine
基金
武汉药学会资助项目(WHPA2022020033)。
关键词
英夫利昔单抗
血清病样反应
炎症性肠病
Infliximab
Serum sickness-like reaction
Inflammatory bowel disease